Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Non Operating Income: 2021-2025

Historic Non Operating Income for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to $5.1 million.

  • Immunocore Holdings' Non Operating Income fell 43.52% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year increase of 24.61%. This contributed to the annual value of $14.2 million for FY2024, which is 1682.83% up from last year.
  • As of Q3 2025, Immunocore Holdings' Non Operating Income stood at $5.1 million, which was up 7.86% from $4.7 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Non Operating Income high stood at $9.0 million for Q3 2024, and its period low was -$1.8 million during Q4 2021.
  • Its 3-year average for Non Operating Income is $2.6 million, with a median of $993,000 in 2024.
  • In the last 5 years, Immunocore Holdings' Non Operating Income surged by 4,767.71% in 2024 and then slumped by 43.52% in 2025.
  • Over the past 4 years, Immunocore Holdings' Non Operating Income (Quarterly) stood at -$1.8 million in 2021, then reached -$191,000 in 2023, then skyrocketed by 619.90% to $993,000 in 2024, then slumped by 43.52% to $5.1 million in 2025.
  • Its Non Operating Income stands at $5.1 million for Q3 2025, versus $4.7 million for Q2 2025 and $5.5 million for Q1 2025.